Idiopathic Pulmonary Fibrosis: Drugs
The question
To ask the Secretary of State for Health and Social Care, whether his Department has considered the implications of the UK-US Economic Prosperity Deal for the potential approval of Jascayd (nerandomilast).
Answered by Dr Zubir Ahmed
No specific consideration of the implications of the United Kingdom and United States’ Economic Prosperity Deal for the approval of Jascayd (nernadomilast) has been made. The changes that we are making to the way in which the National Institute for Health and Care Excellence (NICE) evaluates medicines are expected to increase the number of medicines that NICE is able to recommend for National Health Service use. NICE will continue to develop its recommendations on whether individual medicines should be routinely funded by the NHS independently on the basis of the available evidence and through extensive engagement with interested parties.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →